October 26, 2021
(Reuters) – Eli Lilly and Co on Tuesday reported an 8% fall in third quarter profit, reflecting higher research and development costs.
Net income fell to $1.11 billion or $1.22 per share, in the quarter ended Sept. 30, from $1.21 billion, or $1.33 per share a year earlier.
(Reporting by Manojna Maddipatla and Mrinalika Roy in Bengaluru; Editing by Tomasz Janowski)
Source: One America News Network
